Early access to syn023 for rabies treatment
Part of Infections clinical trials.
This trial provides access to an experimental medicine (SYN023) for people with rabies who have no other options. It aims to treat the infection, but since there is no standard cure, this is a special program for urgent cases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You cannot get other approved or experimental treatments for rabies, or you do not have access to them.
- No standard cure is available for your condition.
- Your doctor must think it is safe for you to receive this treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new rabies vaccine given before any exposure to the virus, to help prevent infection. It aims to see if the vaccine is safe and creates a strong immune response in healthy people.
This trial tests different doses of a rabies vaccine to see how well they protect against rabies and how safe they are. It's for healthy adults who may need rabies protection, for example after an animal bite or as routine prevention.
This trial tests a new rabies vaccine to see if it's safe and effective. It's for people who haven't been vaccinated against rabies or been bitten by a rabies-risk animal recently.
This study tests whether a new experimental rabies vaccine, when given with the standard rabies vaccine, is safe and helps the body build a strong immune response. It aims to find a better way to protect against rabies.
This trial tests a new freeze-dried rabies vaccine grown in human cells. It aims to confirm the vaccine is safe and works well for people aged 10 to 60 who have not been vaccinated against rabies before and have not been recently bitten by a rabid animal. By joining, you help ensure that a reliable vaccine is available to protect against this serious disease.
This study looks at how well the rabies treatment SYN023 works in children under 18 who have had a high-risk (Category III) animal bite. It tests a combination of medications given right after the bite to prevent rabies.
Hear when a new Rabies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.